CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
  • US
    • US
    • EUROPE
    • APAC
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How Regulatory has Become Strategically...

Caroline Herody, Head of Global Regulatory...

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of...

Strategies for RIM system Selection when...

Joel Finkle, Associate Director, Regulatory...

How to Manage Regulatory Compliance

Scott Cleve, Vice President Regulatory Operations...

Maintaining Regulatory Impacts

Robyn Meurant, Executive Director, Regulatory...

How Technology is Disrupting the Pharma...

Colin Boatwright, CIO, Ironshore Pharmaceuticals Inc

Specialized Services: A New Paradigm in...

Brian D. Fry, Senior Director, Cell Therapy CDMO,...

Setting A Culture for Digital...

Ross Kenyon, Associate Director – Modeling,...

How Regulatory has Become Strategically...

Caroline Herody, Head of Global Regulatory...

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of...

Strategies for RIM system Selection when...

Joel Finkle, Associate Director, Regulatory...

How to Manage Regulatory Compliance

Scott Cleve, Vice President Regulatory Operations...

Maintaining Regulatory Impacts

Robyn Meurant, Executive Director, Regulatory...

How Technology is Disrupting the Pharma...

Colin Boatwright, CIO, Ironshore Pharmaceuticals Inc

Specialized Services: A New Paradigm in...

Brian D. Fry, Senior Director, Cell Therapy CDMO,...

Setting A Culture for Digital...

Ross Kenyon, Associate Director – Modeling,...

Three Steps To Succeed With Digital Transformation In Pharma?

Philippe Caby, CIO, Centrient Pharmaceuticals
Tweet

Even if all budgets will be constrained in the post Covid economy, expectations on digital transformation will continue to grow because pharma companies need, more than ever before the sustainable competitive advantages it can deliver. Although the evolution of technology enablers has never been so fast, a lot of digital transformation will still be failing to deliver these expected benefits. Here are a couple of steps to maximize the chances of success of digital transformation in pharma:


Step number one addresses the “WHY”: defining the digital transformation purpose. Depending on your company, it can go from improved customer experience, compliant manufacturing, operational excellence, accelerated product development, …


Since the beginning of my career, twenty years ago, the technologies available have grown exponentially. So, it has become more and more important to structure the choice of the technologies that have the highest potential to enable our business goals. Indeed, technology is not an aim per se in the pharma industry, and this step will be key to focus investments where it can add maximum value to your company.


Technology investments have to be agreed at the highest level with the executive committee (incl. the CEO) to make sure your digital transformation is aligned to the overall enterprise strategy. This is also a way to ensure the appropriate level of change management and sponsorship from the line management to effectively land new solutions in the operations. It is incredibly hard to agree on a way to measure success of technology initiatives when you create silos between functions. Off course tracking per function is good for the cost part of the equation, but the value part is much easier to measure at enterprise level. Doing so will also generate enterprise thinking and collaboration to reach a shared goal.


Aligning on the purpose also requires IT to partner with each function of the company showing deep understanding of their business. Ideally, each business leadership team should include an IT representative to develop this partnership. These profiles can come from a technology, consulting or business background, but need to use those three competencies to succeed.


Once the digital transformation purpose is defined and you’ve agreed on business measures of success with the sponsors, it will serve as an input to choose which initiatives will be launched. While the overall portfolio and value delivery needs to be tracked at the highest level, each initiative can be executed by autonomous teams under the leadership of its sponsor. In order to do so, these teams will include IT partners, technology enablers, business leaders and representatives of the users.


As technology leaders, we need to choose the right profiles, right technologies and the right external partners to implement them. The number of technologies needs to be aligned to your organization capacity. Start small with external partners and fail fast or decide to scale up based on the outcome. Sustainable digital transformation programs should be funded by the value they deliver in the business rather than by risky cost cutting or increased technical debt on core IT applications.


Multi-purpose technologies that can enable several initiatives should come on top of your list. Adjust your risk appetite to the size of the opportunity, with no compromise on compliance.


This leads to the last step which is about the speed of your digital transformation. Looking at technology across industries, I see a pattern in the development of new technologies where overinvestment is often followed by failures before disruption leads to new market dynamics. I believe that digital transformation is no exception to that. The burst of the “dot coms” bubble happened 20 years ago, and the most successful companies in the world are now on internet.


The third step is then to carefully manage the timing of your digital transformation. It needs to be fast enough to accelerate your business but also adjusted to the pace of adoption in your company. Agile methodology with its focus on value flow and quality, is of great help to get this right. This is not only valid for internal teams working on your digital initiatives, but also for your partnership with external vendors. The procurement function needs to be brought along in this journey. Agility needs to be built in our contracts allowing to share rewards, but also risks across companies. Three years SaaS contracts without possibility to exit when results don’t follow are over. Prices need to be based on usage.


In summary, successful digitalization should:


1.serve a transformation purpose aligned to your company strategy and agreed with the Executive Committee.


2.Focus their technology choices and be executed by a multidisciplinary team including representatives of the users.


3.Apply Agile principles to adjust its timing with the investment capacity of the company, maturity of the technology market, user adoption and business outcome delivered


Weekly Brief

loading
Top 10 Regulatory Services Companies - 2022
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue

Read Also

A Tale of Transformational Leadership in the IT&S Setting

Pam Banchy, CIO, VP Clinical Informatics, Western Reserve Hospital/Western Reserve Health System

The CIO's Spice Rack

Praseed Thapparambil, CIO, National Assoc. of Boards of Pharmacy

Technology Enables Patient Empowerment

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI Research

Data Governance is Relatively New to the Healthcare Industry

William Phillips,SVP & CIO,University Health System

DNA Infusion-Providing an Identity and Voice to Pharmaceuticals

Judy Murrah, CIO, Applied DNA Sciences Inc

Beyond the Pill, IT Leads the Technology Revolution at Teva Pharmaceuticals

Guy Hadari, VP & CIO, Teva Pharmaceuticals

The Process And Culture Requirements For Exceptional Regulatory Technology

Greg Bellotti, Vice President IT/CIO, Elementis Global
Loading...

Copyright © 2022 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://regulatory-services.lifesciencesreview.com/cioviewpoint/three-steps-to-succeed-with-digital-transformation-in-pharma-nwid-811.html